Methamphetamine - UCLA Integrated Substance Abuse Programs

More documents

Recommendations

Info

MA Psychosis Inpatients from 4 CountriesPsychotic symptomPersecutory delusionAuditory hallucinationsStrange or unusual beliefsThought readingVisual hallucinationsDelusion of referenceThought insertion or made actNegative psychotic symptomsDisorganized speechDisorganized or catatonic behaviorNo. of patients havingsymptoms (%)Lifetime130 (77.4)122 (72.6)98 (58.3)89 (53.0)64 (38.1)64 (38.1)56 (33.3)Current35 (20.8)75 (44.6)39 (23.2)27 (16.1)38 (22.6)20 (11.9)18 (10.7)36 (21.4)19 (11.3)14 (8.3)Srisurapanont et al., 2003
MA Psychosis‣ 69 physically healthy, incarcerated Japanesefemales with hx MA use• 22 (31.8%) no psychosis• 47 (68.2%) psychosis• 19 resolved (mean=276.2±222.8 222.8 days)• 8 persistent (mean=17.6±10.5 10.5 months)• 20 flashbackers (mean=215.4±208.2 208.2 days to initialresolution)• 11 single flashback• 9 Recurrent flashbacks Yui2001Yui et al.,‣ Polymorphism in DAT Gene associated with MApsychosis in JapaneseUjike et al., 2003
Page 1: Methamphetamine: Modifications in B
Page 10: Respiratory Disorders and MA Use‣
Page 13: In other words:A Major Reason Peopl
Page 22 and 23: Meth
Page 24 and 25: dopaminereservoirsynapse
Page 26 and 27: Prolonged Drug Use ChangesThe Brain
Page 28 and 29: Effects of Drugs on Dopamine Releas
Page 30 and 31: Control> MA43210
Page 32 and 33: Labeling of EmotionBrain scans were
Page 34 and 35: How muchdoes the brain heal?
Page 36 and 37: Partial Recovery of Brain DopamineT
Page 38 and 39: Methamphetamine Use, Self-Reported
Page 40 and 41: Neural Activation Patterns ofMetham
Page 42 and 43: Results Continued‣ 9 areas within
Page 44 and 45: Implications of Results• Neural a
Page 46 and 47: Acute MA Psychosis‣ Extreme Paran
Page 50 and 51: MAT-SS Psychiatric andMedical Studi
Page 52 and 53: Study I: Epidemiology of Psychiatri
Page 54 and 55: Association of Diagnoses with Outco
Page 56 and 57: Results: Major Depressive DisorderR
Page 58 and 59: ‣ HypothesesStudy III: Psychotic
Page 60 and 61: ‣ AimStudy IV: Risk Factors for D
Page 62 and 63: ‣ AimStudy V: Risk Factors for Su
Page 64 and 65: Study VI: Medical Illness in MA Use
Page 66 and 67: Prenatal Meth. Exposure‣ Prelimin
Page 68 and 69: My Sexual Pleasure isEnhanced by th
Page 70 and 71: Behavior Symptom Inventory(BSI) Sco
Page 72 and 73: Hepatitis C by Route50454440% Preve
Page 74 and 75: Clinical Challenges with Methamphet
Page 76 and 77: Why the “MA treatment doesn’two
Page 78 and 79: StatisticsAnalysis of:‣ Drop out
Page 81 and 82: MA Treatment Issues‣ Acute MA Ove
Page 83 and 84: Psychostimulant WithdrawalCrash(Day
Page 85 and 86: Pharmacotherapies for Psychostimula
Page 87 and 88: Initiating MA Abstinence‣ Key Cli
Page 89 and 90: Treatment Resources‣ Methamphetmi

Methamphetamine - UCLA Integrated Substance Abuse Programs

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?